Всероссийская GMP-конференция | Новости
News
02/10/2020 Establishment of the single EAEU market remains one of the most discussed topics in the context of good practices development

Establishment of the single EAEU market remains one of the most discussed topics in the context of good practices development. In this respect, the V All-Russian GMP Conference initiated a…

02/10/2020 The V All-Russian GMP Conference Expands International Cooperation

The list of important partners includes PRO.MED.CS Praha a.s., a leading Czech pharmaceutical company supplying its products to 26 countries. Mainly, it supplies its products to the Russian Federation, countries of the Central and Eastern Europe and the Middle East. The company has its own scientific and research base and specialises in the production of final dosage forms used to treat the digestive, cardiovascular and nervous systems. The main mission of the company, as PRO.MED.CS Praha a.s. sees it, is to provide patients with tested and safe drugs at a reasonable price.

02/10/2020 Nacimbio Vaccines: Building Internal Potential

Despite the fact that the coronavirus prevails in the media space, we should not forget that the risk of influenza infection is still here.

29/09/2020 Roche Company is a Strategic Partner of the V All-Russian GMP Conference

The All-Russian GMP Conference with international participation pays special attention to the development of innovations and advanced approaches to the organisation of pharmaceuticals and medical equipment production.

29/09/2020 MSD Pharmaceuticals is the General Partner of the V All-Russian GMP Conference

The COVID-19 pandemic has posed a number of challenges to the entire economy, state and society. The year 2020 is not an easy one also for the pharmaceutical industry that found itself in the epicentre of the fight against the pandemic. In this context, the V All-Russian GMP Conference participants will pay much attention to the matters of development in these new conditions.

28/09/2020 Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies

Agreement will significantly increase global supply capacity for Lilly’s potential COVID-19 treatments.

28/09/2020 On October 1, a master class titled New Formats of GMP Inspection is to take place within the V All-Russian GMP Conference

On October 1, a master class titled New Formats of GMP Inspection is to take place within the V All-Russian GMP Conference. The block Practice. New Formats of GMP Inspection:…

25/09/2020 The V All-Russian GMP Conference takes pride in its longstanding partnership with leading companies. Abbott Company develops new products and technologies in such spheres as diagnostics, research, production of minimally invasive medical devices and pharmaceutical products.

Abbott is one of the largest global diversified healthcare companies operating in 160 countries. In Russia, Abbott was one of the first foreign investors when it started baby food production here more than 40 years ago.

25/09/2020 On September 30, the agenda of the 5th All-Russia GMP Conference with international participation will include a roundtable discussion “Continuous Production” involving a report to be delivered by Sokrat Kiridzis, the Novartis Area Manager for the Development and Regulatory Support of Anti-Cancer Medicines

Continuous production has become an urgent issue recently. This is a best practice that enables to optimize production, and introduce pharmaceutical products of uniform quality meeting all GMP requirements.